Nano Labs vs Ostin Technology
NA and OST side by side, both in electronic components and accessories. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How NA and OST compare
Ostin Technology grew revenue faster over the last twelve months (22.2% versus −33.5% for Nano Labs).
Nano Labs scores higher on the StockData Score (5 against 2 for Ostin Technology), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | NA | OST |
|---|---|---|
| Size and price | ||
| Share price | $1.38 | $1.70 |
| Change, 1 year | −69.6% | 0.00% |
| Beta (5Y) | 0.97 | 0.65 |
| Employees | 67 | 23 |
| StockData Score | ||
| Total score | 5 (better) | 2 |
| Valuation score | 0 | 0 |
| Growth score | 0 | 2 (better) |
| Performance score | 4 (better) | 0 |
| Health score | 1 (better) | 0 |
| Dividend score | 0 | 0 |
| Growth | ||
| Revenue growth (TTM) | −33.5% | 22.2% (better) |
| Revenue growth, 5Y average | 66.2% (better) | −22.3% |
| Profitability | ||
| Gross margin | −147% | 6.4% (better) |
| Operating margin | 264% (better) | −22.9% |
| Net margin | 502% | – |
| FCF margin | −401% | −17.9% (better) |
| Return on equity | 26.5% | – |
| Return on invested capital | 10.7% (better) | −28.3% |
| Financial health | ||
| Debt / equity | 0.51 (better) | 10.06 |
| Net debt / EBITDA | 2.34 | – |
| Interest coverage | 4.2× (better) | −64.0× |
| Current ratio | 1.20 (better) | 0.37 |
| Piotroski F-score | 4 | – |
| Ownership | ||
| Held by insiders | 42.4% | 0.00% |
| Insider net buying, 12 months | −$85.1K | – |
| Short interest, % of float | – | 0.12% |
Go deeper
- NA stock overview
- NA income statement
- NA valuation and score
- OST stock overview
- OST income statement
- OST valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.